Np mrd loader

Record Information
Version2.0
Created at2024-09-11 19:29:35 UTC
Updated at2024-09-11 19:29:35 UTC
NP-MRD IDNP0339059
Secondary Accession NumbersNone
Natural Product Identification
Common Name17-HETE
Description 17-HETE was first documented in 2014 (PMID: 25065748). Based on a literature review a significant number of articles have been published on 17-HETE (PMID: 37244564) (PMID: 34904633) (PMID: 34591339) (PMID: 34158817) (PMID: 32900329) (PMID: 30543782).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC20H32O3
Average Mass320.4730 Da
Monoisotopic Mass320.23514 Da
IUPAC Name(5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid
Traditional Name17-hete
CAS Registry NumberNot Available
SMILES
CCCC(O)C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O
InChI Identifier
InChI=1/C20H32O3/c1-2-16-19(21)17-14-12-10-8-6-4-3-5-7-9-11-13-15-18-20(22)23/h3,5-6,8-9,11-12,14,19,21H,2,4,7,10,13,15-18H2,1H3,(H,22,23)/b5-3-,8-6-,11-9-,14-12-
InChI KeyOPPIPPRXLIDJKN-JPURVOHMNA-N
Experimental Spectra
Not Available
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of OriginNot Available
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP5.2ChemAxon
pKa (Strongest Acidic)4.82ChemAxon
pKa (Strongest Basic)-1.3ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area57.53 ŲChemAxon
Rotatable Bond Count14ChemAxon
Refractivity101.62 m³·mol⁻¹ChemAxon
Polarizability38 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Isse FA, Alammari AH, El-Sherbeni AA, El-Kadi AOS: 17-(R/S)-hydroxyeicosatetraenoic acid (HETE) induces cardiac hypertrophy through the CYP1B1 in enantioselective manners. Prostaglandins Other Lipid Mediat. 2023 Oct;168:106749. doi: 10.1016/j.prostaglandins.2023.106749. Epub 2023 May 25. [PubMed:37244564 ]
  2. Gong Y, Ni X, Jin C, Li X, Wang Y, Wang O, Li M, Xing X, Wu Z, Jiang Y, Xia W: Serum Metabolomics Reveals Dysregulation and Diagnostic Potential of Oxylipins in Tumor-induced Osteomalacia. J Clin Endocrinol Metab. 2022 Apr 19;107(5):1383-1391. doi: 10.1210/clinem/dgab885. [PubMed:34904633 ]
  3. Nagata N, Hamasaki Y, Inagaki S, Nakamura T, Horikami D, Yamamoto-Hanada K, Inuzuka Y, Shimosawa T, Kobayashi K, Narita M, Ohya Y, Murata T: Urinary lipid profile of atopic dermatitis in murine model and human patients. FASEB J. 2021 Nov;35(11):e21949. doi: 10.1096/fj.202100828R. [PubMed:34591339 ]
  4. Zhu Z, Zhou W, Yang Y, Wang K, Li F, Dang Y: Quantitative Profiling of Oxylipin Reveals the Mechanism of Pien-Tze-Huang on Alcoholic Liver Disease. Evid Based Complement Alternat Med. 2021 Jun 1;2021:9931542. doi: 10.1155/2021/9931542. eCollection 2021. [PubMed:34158817 ]
  5. Cioccari L, Luethi N, Duong T, Ryan E, Cutuli SL, Lloyd-Donald P, Eastwood GM, Peck L, Young H, Vaara ST, French CJ, Orford N, Dwivedi J, Lankadeva YR, Bailey M, Reid GE, Bellomo R: Cytokine and lipid metabolome effects of low-dose acetylsalicylic acid in critically ill patients with systemic inflammation: a pilot, feasibility, multicentre, randomised, placebo-controlled trial. Crit Care Resusc. 2020 Sep;22(3):227-236. doi: 10.1016/S1441-2772(23)00390-3. [PubMed:32900329 ]
  6. Shoieb SM, El-Sherbeni AA, El-Kadi AOS: Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states. Chem Biol Interact. 2019 Feb 1;299:140-150. doi: 10.1016/j.cbi.2018.12.004. Epub 2018 Dec 10. [PubMed:30543782 ]
  7. Anwar-Mohamed A, Elshenawy OH, El-Sherbeni AA, Abdelrady M, El-Kadi AO: Acute arsenic treatment alters arachidonic acid and its associated metabolite levels in the brain of C57Bl/6 mice. Can J Physiol Pharmacol. 2014 Aug;92(8):693-702. doi: 10.1139/cjpp-2014-0136. [PubMed:25065748 ]